TPIDB > 臨床試驗主持人
臨床試驗主持人
更新時間：2023-09-19
葉昭廷Yeh, Chau-Ting
- 計畫主持人
- 執行臨床試驗年資 17 年 9 個月
-
chauting@cgmh.org.tw
發表文獻
18筆
11
Shao C, Shao PP, Chen WT, Lin CC, Lin WR, Yeh CT. Direct-acting Antiviral Therapy Improves the Outcome of Chronic Hepatitis C/intermediate-stage B Hepatocellular Carcinoma Patients. Anticancer Res. 2021 Apr;41(4):2007-2016. doi: 10.21873/anticanres.14968. PMID: 33813407.
12
Hsu CW, Chu YD, Lai MW, Lin CL, Liang KH, Lin YH, Yeh CT. Hepatitis B Virus Covalently Closed Circular DNA Predicts Postoperative Liver Cancer Metastasis Independent of Virological Suppression. Cancers (Basel). 2021 Jan 31;13(3):538. doi: 10.3390/cancers13030538. PMID: 33572617; PMCID: PMC7867012.
13
Chen TH, Cheng HT, Yeh CT. Epidemiology changes in peptic ulcer diseases 18 years apart explored from the genetic aspects of Helicobacter pylori. Transl Res. 2021 Jun;232:115-120. doi: 10.1016/j.trsl.2020.12.006. Epub 2020 Dec 19. PMID: 33352297.
14
Lai MW, Liang KH, Yeh CT. Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbi. Int J Mol Sci. 2020 Sep 2;21(17):6366. doi: 10.3390/ijms21176366. PMID: 32887289; PMCID: PMC7503731.
15
Lin CL, Chien RN, Chu YD, Liang KH, Huang YH, Ke PY, Lin KH, Lin YH, Yeh CT. Hepatitis B virus X gene mutants emerge during antiviral therapy and increase cccDNA levels to compensate for replication suppression. Hepatol Int. 2020 Dec;14(6):973-984. doi: 10.1007/s12072-020-10079-1. Epub 2020 Aug 7. PMID: 32770306.
16
Chu YD, Yeh CT. The Molecular Function and Clinical Role of Thyroid Stimulating Hormone Receptor in Cancer Cells. Cells. 2020 Jul 20;9(7):1730. doi: 10.3390/cells9071730. PMID: 32698392; PMCID: PMC7407617.
17
Chu YD, Lin WR, Lin YH, Kuo WH, Tseng CJ, Lim SN, Huang YL, Huang SC, Wu TJ, Lin KH, Yeh CT. COX5B-Mediated Bioenergetic Alteration Regulates Tumor Growth and Migration by Modulating AMPK-UHMK1-ERK Cascade in Hepatoma. Cancers (Basel). 2020 Jun 22;12(6):1646. doi: 10.3390/cancers12061646. PMID: 32580279; PMCID: PMC7352820.
18
Lin WR, Yeh CT. GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers. Int J Mol Sci. 2020 Feb 21;21(4):1491. doi: 10.3390/ijms21041491. PMID: 32098271; PMCID: PMC7073045.
1
2
